PIACERI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 3.520
EU - Europa 1.755
AS - Asia 364
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 5.641
Nazione #
US - Stati Uniti d'America 3.512
PL - Polonia 730
IT - Italia 314
IE - Irlanda 274
SE - Svezia 205
CN - Cina 137
HK - Hong Kong 114
DE - Germania 54
UA - Ucraina 41
JO - Giordania 37
GB - Regno Unito 36
FI - Finlandia 34
RU - Federazione Russa 32
IN - India 24
SG - Singapore 18
VN - Vietnam 17
ES - Italia 12
TR - Turchia 10
CA - Canada 8
BE - Belgio 7
CH - Svizzera 7
FR - Francia 6
JP - Giappone 5
NL - Olanda 2
CZ - Repubblica Ceca 1
EU - Europa 1
IR - Iran 1
KR - Corea 1
PE - Perù 1
Totale 5.641
Città #
Warsaw 730
Fairfield 550
Ashburn 505
Chandler 274
Dublin 272
Woodbridge 270
Seattle 254
Houston 253
Cambridge 227
Wilmington 172
Altamura 123
Ann Arbor 122
Lawrence 118
Dearborn 82
Princeton 78
Hong Kong 64
Beijing 61
Florence 56
Boston 51
Buffalo 45
San Diego 35
Bremen 31
Moscow 29
Medford 26
Boardman 24
Pune 23
Jacksonville 21
Hefei 15
New York 14
Dong Ket 13
Falls Church 13
Norwalk 13
Hillsboro 11
Shanghai 11
Barcelona 10
Izmir 10
Jinan 9
Singapore 9
Nanjing 8
Toronto 8
Andover 7
Bern 7
Brussels 7
Kunming 7
Redwood City 7
London 6
Cagliari 5
Misano Adriatico 5
Phoenix 5
Stia 5
Kilburn 4
Rome 4
Castelfidardo 3
Castelliri 3
Chengdu 3
Fuzhou 3
Guangzhou 3
Jamaica 3
Milan 3
Prescot 3
Salerno 3
Santa Maria A Monte 3
Siena 3
Spoltore 3
Turin 3
Zhengzhou 3
Afragola 2
Barletta 2
Bloomsbury 2
Bologna 2
Casamarciano 2
Chiswick 2
Chongqing 2
Cosenza 2
Dallas 2
Genoa 2
Hounslow 2
Naples 2
New Bedfont 2
Pontedera 2
Prato 2
Rosolini 2
Vandoeuvre 2
Wenzhou 2
Wuhan 2
Acireale 1
Ardabil 1
Bagno A Ripoli 1
Bari 1
Brentford 1
Brookline 1
Böblingen 1
Caserta 1
Catanzaro 1
Changsha 1
Empoli 1
Fermo 1
Fiesole 1
Fremont 1
Gandhi Nagar 1
Totale 4.804
Nome #
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 269
Profilo Genetico ed Epigenetico in pazienti con Demenza Frontotemporale 266
FDG PET and the genetics of dementia 220
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 218
Association Study of Genetic Variants in CDKN2A/CDKN2B genes/Loci with Late-Onset Alzheimer's Disease 189
Notch4 and mhc class II polymorphisms are associated with hcv-related benign and malignant lymphoproliferative diseases 155
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 147
A PALB2 germline mutation associated with hereditary breast cancer in Italy. 134
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 115
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 114
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 103
Analyses of the role of the glucocorticoid receptor gene polymorphism (rs41423247) as a potential moderator in the association between childhood overweight, psychopathology, and clinical outcomes in Eating Disorders patients: A 6 years follow up study. 100
Ataxia-telangiectasia mutated (ATM) genetic variant in Italian centenarians 98
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 97
Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications. 95
Tumor necrosis factor α influences phenotypic plasticity and promotes epigenetic changes in human basal forebrain cholinergic neuroblasts 95
Primary Progressive Aphasia: Natural History in an Italian Cohort 92
Biomarkers study in atypical dementia: proof of a diagnostic work-up 91
Autosomal Dominant Frontotemporal Lobar Degeneration Due to the C9ORF72 Hexanucleotide Repeat Expansion: Late-Onset Psychotic Clinical Presentation 90
Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (Scientific Reports (2017) DOI: 10.1038/s41598-017-09320-z) 86
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 86
Genetics of familial and sporadic Alzheimer's disease. 84
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia 84
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 83
Progranulin genetic screening in frontotemporal lobar degeneration patients from central Italy. 81
Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease 81
Effects of Multiple Genetic Loci on Age at Onset in Frontotemporal Dementia 81
Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation 78
DAPK1 is Associated with FTD and not with Alzheimer's Disease 78
Association of the Variant Cys139Arg at GRN Gene to the Clinical Spectrum of Frontotemporal Lobar Degeneration 77
Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease. 75
Suitability of neuropsychological tests in patients with vascular dementia (VaD). 75
Genetics of Alzheimer's Disease and Frontotemporal Dementia 75
Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration 72
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 72
Folate, Homocysteine, Vitamin B12, and Polymorphisms of Genes Participating in One-Carbon Metabolism in Late-Onset Alzheimer's Disease Patients and Healthy Controls 72
Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships 72
Correction: Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 69
Clinical heterogeneity in Italian patients with amyotrophic lateral sclerosis 68
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. 68
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 68
A Pan-European study of theC9orf72Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability and Intermediate Repeats 67
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia 67
Tomm40 polymorphisms in Italian Alzheimer’s disease and frontotemporal dementia patients 65
Novel presenilin 1 mutation (Ile408Thr) in an Italian family with late-onset Alzheimer's disease 65
Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia 64
Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol 64
Mitochondria and Alzheimer's disease. 62
Heterozygous TREM2 mutations in frontotemporal dementia 62
No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients 59
Epigenetic modifications in Alzheimer's disease: Cause or effect? 59
CXCR4 involvement in neurodegenerative diseases 58
Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis 58
Frontotemporal dementia and its subtypes: a genome-wide association study 55
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 54
Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases 53
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 51
Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease 43
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 42
Cholesteryl ester transfer protein (CETP) I405V polymorphism in Italian memory complainers 40
"stato dell'arte" della ricerca 40
Incomplete penetrance in familial Alzheimer’s disease with PSEN1 Ala260Gly mutation 39
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 38
Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians 37
C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts 32
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 26
Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes 22
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 19
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 19
Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia 17
Totale 5.750
Categoria #
all - tutte 16.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.009


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019439 0 0 0 0 0 0 0 0 0 97 193 149
2019/20201.465 80 92 36 96 173 197 224 181 163 96 96 31
2020/2021780 74 78 69 111 29 55 32 69 65 116 43 39
2021/2022521 16 30 50 22 13 28 16 42 27 22 92 163
2022/20231.288 136 307 47 120 68 213 167 58 125 9 25 13
2023/2024669 30 52 75 26 32 69 25 334 10 16 0 0
Totale 5.750